标题
The expanding role of prodrugs in contemporary drug design and development
作者
关键词
-
出版物
NATURE REVIEWS DRUG DISCOVERY
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2018-04-27
DOI
10.1038/nrd.2018.46
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Prodrug strategy for cancer cell-specific targeting: A recent overview
- (2017) Xian Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- 177Lu-PSMA-617 radioligand therapy and outcome in patients with metastasized castration-resistant prostate cancer
- (2017) Axel Bräuer et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prodrugs – Recent approvals and a glimpse of the pipeline
- (2017) Jarkko Rautio et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Immunotherapy for head and neck cancer: the future of treatment?
- (2017) Xiujie Xie et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Reaction phenotyping to assess victim drug-drug interaction risks
- (2017) Li Di Expert Opinion on Drug Discovery
- Inhibitors of HIV-1 Attachment: The Discovery and Development of Temsavir and its Prodrug Fostemsavir
- (2017) Nicholas A. Meanwell et al. JOURNAL OF MEDICINAL CHEMISTRY
- In Vitro – In Vivo Extrapolation of Intestinal Availability for Carboxylesterase Substrates Using Portal Vein–Cannulated Monkey
- (2017) Patrick E. Trapa et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Pharmacologic Characterization of Valbenazine (NBI-98854) and Its Metabolites
- (2017) Dimitri E. Grigoriadis et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- A Physiologically Based Pharmacokinetic Model for Ganciclovir and Its Prodrug Valganciclovir in Adults and Children
- (2016) V. Lukacova et al. AAPS Journal
- Proteases in cancer drug delivery
- (2016) Jennifer Vandooren et al. ADVANCED DRUG DELIVERY REVIEWS
- Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus
- (2016) Adrian S. Ray et al. ANTIVIRAL RESEARCH
- Tenofovir alafenamide (TAF) as the successor of tenofovir disoproxil fumarate (TDF)
- (2016) Erik De Clercq BIOCHEMICAL PHARMACOLOGY
- Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space
- (2016) Nicholas A. Meanwell CHEMICAL RESEARCH IN TOXICOLOGY
- Selexipag: First Global Approval
- (2016) Lesley J. Scott DRUGS
- Lisdexamfetamine: A pharmacokinetic review
- (2016) Eloisa Comiran et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- The codrug approach for facilitating drug delivery and bioactivity
- (2016) Ibrahim A. Aljuffali et al. Expert Opinion on Drug Delivery
- Nucleoside Phosphate and Phosphonate Prodrug Clinical Candidates
- (2016) Peter J. Thornton et al. JOURNAL OF MEDICINAL CHEMISTRY
- Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
- (2016) Travis K. Warren et al. NATURE
- Evaluation of the GastroPlus™ Advanced Compartmental and Transit (ACAT) Model in Early Discovery
- (2016) N. Gobeau et al. PHARMACEUTICAL RESEARCH
- Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy
- (2016) Ralf A. Linker et al. Therapeutic Advances in Chronic Disease
- Antibody Drug Conjugates: Design and Selection of Linker, Payload and Conjugation Chemistry
- (2015) Jessica R. McCombs et al. AAPS Journal
- Intracellular Activation of Tenofovir Alafenamide and the Effect of Viral and Host Protease Inhibitors
- (2015) Gabriel Birkus et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of the Hepatitis C Virus NS5B Polymerase Inhibitor Sofosbuvir
- (2015) Brian J. Kirby et al. CLINICAL PHARMACOKINETICS
- Tafluprost/Timolol: A Review in Open-Angle Glaucoma or Ocular Hypertension
- (2015) Sheridan M. Hoy DRUGS
- Rapid conversion of the ester prodrug abiraterone acetate results in intestinal supersaturation and enhanced absorption of abiraterone: In vitro, rat in situ and human in vivo studies
- (2015) Jef Stappaerts et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Selexipag: An Oral and Selective IP Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial Hypertension
- (2015) Tetsuo Asaki et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antibody–Drug Conjugates and Small Molecule–Drug Conjugates: Opportunities and Challenges for the Development of Selective Anticancer Cytotoxic Agents
- (2015) Giulio Casi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Substrate-Competitive Activity-Based Profiling of Ester Prodrug Activating Enzymes
- (2015) Hao Xu et al. MOLECULAR PHARMACEUTICS
- NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study
- (2015) Christopher F. O'Brien et al. MOVEMENT DISORDERS
- Principles in the design of ligand-targeted cancer therapeutics and imaging agents
- (2015) Madduri Srinivasarao et al. NATURE REVIEWS DRUG DISCOVERY
- CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors
- (2015) X Wang et al. PHARMACOGENOMICS JOURNAL
- Gene-Directed Enzyme Prodrug Therapy
- (2014) Jin Zhang et al. AAPS Journal
- Synthesis of Nucleoside Phosphate and Phosphonate Prodrugs
- (2014) Ugo Pradere et al. CHEMICAL REVIEWS
- Physiologically Based Pharmacokinetic Modeling of Impaired Carboxylesterase-1 Activity: Effects on Oseltamivir Disposition
- (2014) Zhe-Yi Hu et al. CLINICAL PHARMACOKINETICS
- Enabled clinical use of an HIV-1 attachment inhibitor through drug delivery
- (2014) Peter Timmins et al. DRUG DISCOVERY TODAY
- Application of ProTide Technology to Gemcitabine: A Successful Approach to Overcome the Key Cancer Resistance Mechanisms Leads to a New Agent (NUC-1031) in Clinical Development
- (2014) Magdalena Slusarczyk et al. JOURNAL OF MEDICINAL CHEMISTRY
- Quantitative Assessment of Intestinal First-pass Metabolism of Oral Drugs Using Portal-vein Cannulated Rats
- (2014) Yoshiki Matsuda et al. PHARMACEUTICAL RESEARCH
- Multiple-Dose Up-Titration Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Selexipag, an Orally Available Selective Prostacyclin Receptor Agonist, in Healthy Subjects
- (2014) Shirin Bruderer et al. PHARMACOLOGY
- Randomized phase 2 study of pegylated SN-38 (EZN-2208) or irinotecan plus cetuximab in patients with advanced colorectal cancer
- (2013) Christopher R. Garrett et al. CANCER
- Drug transport via the intestinal peptide transporter PepT1
- (2013) Matthias Brandsch CURRENT OPINION IN PHARMACOLOGY
- Chemistry-enabled drug delivery (prodrugs): recent progress and challenges
- (2013) Sophie-Dorothee Clas et al. DRUG DISCOVERY TODAY
- Cytochrome P450-activated prodrugs
- (2013) Paul R Ortiz de Montellano Future Medicinal Chemistry
- PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer
- (2013) R. Wendel Naumann et al. JOURNAL OF CLINICAL ONCOLOGY
- Compartmental Absorption Modeling and Site of Absorption Studies to Determine Feasibility of an Extended-Release Formulation of an HIV-1 Attachment Inhibitor Phosphate Ester Prodrug
- (2013) Jonathan Brown et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- The Role of Human Carboxylesterases in Drug Metabolism: Have We Overlooked Their Importance?
- (2013) S. Casey Laizure et al. PHARMACOTHERAPY
- The Discovery of Dabigatran Etexilate
- (2013) Joanne van Ryn et al. Frontiers in Pharmacology
- Glutathione Transferase (GST)-Activated Prodrugs
- (2013) Paolo Ruzza et al. Pharmaceutics
- Polymer therapeutics-prospects for 21st century: The end of the beginning
- (2012) Ruth Duncan et al. ADVANCED DRUG DELIVERY REVIEWS
- Amino acids as promoieties in prodrug design and development
- (2012) Balvinder S. Vig et al. ADVANCED DRUG DELIVERY REVIEWS
- Clinical Binding Properties, Internalization Kinetics, and Clinicopathologic Activity of Brentuximab Vedotin: An Antibody-Drug Conjugate for CD30-Positive Lymphoid Neoplasms
- (2012) Jonathan R. Fromm et al. Clinical Lymphoma Myeloma & Leukemia
- Evidence-based approach to assess passive diffusion and carrier-mediated drug transport
- (2012) Li Di et al. DRUG DISCOVERY TODAY
- Dabigatran Etexilate
- (2012) Celeste B. Burness et al. DRUGS
- Population Pharmacokinetics and Pharmacodynamics of Gabapentin After Administration of Gabapentin Enacarbil
- (2012) Ritu Lal et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacodynamics, Safety, and Pharmacokinetics of BMS-663068, an Oral HIV-1 Attachment Inhibitor in HIV-1-Infected Subjects
- (2012) R. E. Nettles et al. JOURNAL OF INFECTIOUS DISEASES
- Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1) Attachment 6. Preclinical and Human Pharmacokinetic Profiling of BMS-663749, a Phosphonooxymethyl Prodrug of the HIV-1 Attachment Inhibitor 2-(4-Benzoyl-1-piperazinyl)-1-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-oxoethanone (BMS-488043)
- (2012) John F. Kadow et al. JOURNAL OF MEDICINAL CHEMISTRY
- Species Difference of Esterase Expression and Hydrolase Activity in Plasma
- (2012) Fatma Goksin Bahar et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Predicting human exposure of active drug after oral prodrug administration, using a joined in vitro/in silico–in vivo extrapolation and physiologically-based pharmacokinetic modeling approach
- (2012) Jonas Malmborg et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Activation of Benznidazole by Trypanosomal Type I Nitroreductases Results in Glyoxal Formation
- (2011) Belinda S. Hall et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity and the metabolic activation pathway of the potent and selective hepatitis C virus pronucleotide inhibitor PSI-353661
- (2011) Phillip A. Furman et al. ANTIVIRAL RESEARCH
- Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and Safety
- (2011) Nicholas A. Meanwell CHEMICAL RESEARCH IN TOXICOLOGY
- The Role of Intestinal Carboxylesterase in the Oral Absorption of Prodrugs
- (2011) Teruko Imai et al. CURRENT DRUG METABOLISM
- Polymer therapeutics as nanomedicines: new perspectives
- (2011) Ruth Duncan CURRENT OPINION IN BIOTECHNOLOGY
- Trypanocidal Activity of Nitroaromatic Prodrugs: Current Treatments and Future Perspectives
- (2011) Shane R. Wilkinson et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Rational Design and Development of Colon-Specific Prodrugs
- (2011) Suneela S. Dhaneshwar et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Bridging solubility between drug discovery and development
- (2011) Li Di et al. DRUG DISCOVERY TODAY
- Characterization of the Expression and Activity of Carboxylesterases 1 and 2 from the Beagle Dog, Cynomolgus Monkey, and Human
- (2011) E. T. Williams et al. DRUG METABOLISM AND DISPOSITION
- Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma
- (2011) Karen M VanderMolen et al. JOURNAL OF ANTIBIOTICS
- Use of Enzyme Inhibitors to Evaluate the Conversion Pathways of Ester and Amide Prodrugs: A Case Study Example with the Prodrug Ceftobiprole Medocaril
- (2011) Gary Eichenbaum et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- CYP2S1 and CYP2W1 Mediate 2-(3,4-Dimethoxyphenyl)-5-Fluorobenzothiazole (GW-610, NSC 721648) Sensitivity in Breast and Colorectal Cancer Cells
- (2011) B. S. Tan et al. MOLECULAR CANCER THERAPEUTICS
- Nanomedicine(s) under the Microscope
- (2011) Ruth Duncan et al. MOLECULAR PHARMACEUTICS
- Prodrugs--from Serendipity to Rational Design
- (2011) K. M. Huttunen et al. PHARMACOLOGICAL REVIEWS
- Enzyme-mediated hydrolytic activation of prodrugs
- (2011) Yan-hui Yang et al. Acta Pharmaceutica Sinica B
- PSI-7851, a Pronucleotide of -D-2'-Deoxy-2'-Fluoro-2'-C-Methyluridine Monophosphate, Is a Potent and Pan-Genotype Inhibitor of Hepatitis C Virus Replication
- (2010) A. M. Lam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prodrug Design to Improve Pharmacokinetic and Drug Delivery Properties: Challenges to the Discovery Scientists
- (2010) S. Jana et al. CURRENT MEDICINAL CHEMISTRY
- Fospropofol
- (2010) Karly P. Garnock-Jones et al. DRUGS
- Mechanism of Activation of PSI-7851 and Its Diastereoisomer PSI-7977
- (2010) Eisuke Murakami et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of a β-d-2′-Deoxy-2′-α-fluoro-2′-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus
- (2010) Michael J. Sofia et al. JOURNAL OF MEDICINAL CHEMISTRY
- Prodrugs: Some Thoughts and Current Issues
- (2010) Valentino J. Stella JOURNAL OF PHARMACEUTICAL SCIENCES
- Randomized Phase III Trial Comparing Single-Agent Paclitaxel Poliglumex (CT-2103, PPX) with Single-Agent Gemcitabine or Vinorelbine for the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer
- (2010) Mary E.R. O'Brien et al. Journal of Thoracic Oncology
- Coexistence of passive and carrier-mediated processes in drug transport
- (2010) Kiyohiko Sugano et al. NATURE REVIEWS DRUG DISCOVERY
- Eslicarbazepine Acetate: A Well-Kept Secret?
- (2010) Epilepsy Currents
- Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
- (2010) Pennick Neuropsychiatric Disease and Treatment
- Population-Based Mechanistic Prediction of Oral Drug Absorption
- (2009) Masoud Jamei et al. AAPS Journal
- Aryloxy Phosphoramidate Triesters: a Technology for Delivering Monophosphorylated Nucleosides and Sugars into Cells
- (2009) Youcef Mehellou et al. ChemMedChem
- Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: A randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers
- (2009) Ritu Lal et al. CLINICAL THERAPEUTICS
- Evaluation of in Vitro Models for Screening Alkaline Phosphatase-Mediated Bioconversion of Phosphate Ester Prodrugs
- (2009) H. Yuan et al. DRUG METABOLISM AND DISPOSITION
- Disposition and Metabolism of a Novel Prostanoid Antiglaucoma Medication, Tafluprost, Following Ocular Administration to Rats
- (2009) Y. Fukano et al. DRUG METABOLISM AND DISPOSITION
- Bimatoprost
- (2009) Monique P. Curran DRUGS & AGING
- Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer
- (2009) Seymour INTERNATIONAL JOURNAL OF ONCOLOGY
- Pharmacokinetics and Pharmacodynamics of Prasugrel, a Thienopyridine P2Y12 Inhibitor
- (2009) Paul P Dobesh PHARMACOTHERAPY
- Clinical Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin??Inhibitor Dabigatran Etexilate
- (2008) Joachim Stangier CLINICAL PHARMACOKINETICS
- Cytochrome P450-Activated Prodrugs: Targeted Drug Delivery
- (2008) Kristiina Huttunen et al. CURRENT MEDICINAL CHEMISTRY
- Synthesis, in vitro and in vivo characterization of novel ethyl dioxy phosphate prodrug of propofol
- (2008) Hanna Kumpulainen et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Fesoterodine: a novel muscarinic receptor antagonist for the treatment of overactive bladder syndrome
- (2008) Martin C Michel EXPERT OPINION ON PHARMACOTHERAPY
- Your Prodrug Releases Formaldehyde: Should You Be Concerned? No!
- (2008) Sundeep S. Dhareshwar et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Discovery and Characterization of Novel Tryptophan Hydroxylase Inhibitors That Selectively Inhibit Serotonin Synthesis in the Gastrointestinal Tract
- (2008) Q. Liu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Prodrugs for Amines
- (2008) Ana Simplício et al. MOLECULES
- Structure and Catalytic Properties of Carboxylesterase Isozymes Involved in Metabolic Activation of Prodrugs
- (2008) Masakiyo Hosokawa MOLECULES
- Prodrugs: design and clinical applications
- (2008) Jarkko Rautio et al. NATURE REVIEWS DRUG DISCOVERY
- Discovery and Development of Folic-Acid-Based Receptor Targeting for Imaging and Therapy of Cancer and Inflammatory Diseases
- (2007) Philip S. Low et al. ACCOUNTS OF CHEMICAL RESEARCH
- Prodrug Strategies in Anticancer Chemotherapy
- (2007) Felix Kratz et al. ChemMedChem
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More